Physicians' Academy for Cardiovascular Education
COVID-19, ACE2 and RAAS inhibition

COVID-19, ACE2 and RAAS inhibition

EBAC-accredited E-Learning

Online-CME - This course consists of 3 parts.

In this educational program the use of RAASi in the management of patients with COVID-19 is discussed in three parts.

This course consists of the following:

After watching these three videos, the learner should be able to:

Expert faculty

Target audience

This educational activity is designed for cardiologists in secondary care and other healthcare professionals with an interest in treating CVD patients.

CME accreditation

This online course is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit.

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.


Funding for this educational program was provided by an unrestricted educational grant from Vifor Pharma and Novartis.


This is available as accredited online CME for members. Click the button below to enroll:


Share this page with your colleagues and friends: